Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn ’s Disease Patients Stratified by Age

ConclusionsThe safety and efficacy of vedolizumab in patients with UC or CD were similar for all age groups. The number of patients in the oldest age group in these analyses was small; thus further studies of vedolizumab in larger cohorts of elderly patients are warranted.FundingMillennium Pharmaceuticals, Inc. (d/b/a Takeda Pharmaceuticals International Co.).

http://link.springer.com/10.1007/s12325-016-0467-6

Source: Advances in Therapy - January 8, 2017 Category: Drugs & Pharmacology Source Type: research